Oncogenetic tree modeling of human hepatocarcinogenesis

Classical comparative genomic hybridization (CGH) has been used to identify recurrent genomic alterations in human HCC. As hepatocarcinogenesis is considered as a stepwise process, we applied oncogenetic tree modeling on all available classical CGH data to determine occurrence of genetic alterations over time. Nine losses (1p, 4q, 6q, 8p, 9p, 13q, 16p, 16q and 17p) and ten gains (1q, 5p, 6p, 7p, 7q, 8q, 17q, 20p, 20q and Xq) of genomic information were used to build the oncogenetic tree model. Whereas gains of 1q and 8q together with losses of 8p formed a cluster that represents early etiology‐independent alterations, the associations of gains at 6q and 17q as well as losses of 6p and 9p were observed during tumor progression. HBV‐induced HCCs had significantly more chromosomal aberrations compared to HBV‐negative tumors. Losses of 1p, 4q and 13q were associated with HBV‐induced HCCs, whereas virus‐negative HCCs showed an association of gains at 5p, 7, 20q and Xq. Using five aberrations that were significantly associated with tumor dedifferentiation a robust progression model of stepwise human hepatocarcinogensis (gain 1q → gain 8q → loss 4q → loss 16q → loss 13q) was developed. In silico analysis revealed that protumorigenic candidate genes have been identified for each recurrently altered hotspot. Thus, oncogenic candidate genes that are coded on chromosome arms 1q and 8q are promising targets for the prevention of malignant transformation and the development of biomarkers for the early diagnosis of human HCC that may significantly improve the treatment options and thus prognosis of HCC patients.

[1]  Rui Li,et al.  Array-based comparative genomic hybridization reveals recurrent chromosomal aberrations and Jab1 as a potential target for 8q gain in hepatocellular carcinoma. , 2005, Carcinogenesis.

[2]  S. Tabata,et al.  Evidence for increased in vitro recombination with insertion of human hepatitis B virus DNA. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[3]  C. Bréchot,et al.  Hepatitis B virus DNA in HBsAg-negative patients. Molecular characterization and clinical implications. , 1991, Journal of hepatology.

[4]  P. Hofschneider,et al.  Hepatoma-derived integrated HBV DNA causes multi-stage transformation in vitro. , 1996, Oncogene.

[5]  A. Schäffer,et al.  Construction of evolutionary tree models for renal cell carcinoma from comparative genomic hybridization data. , 2000, Cancer research.

[6]  K. Boucher,et al.  Estimating an oncogenetic tree when false negatives and positives are present. , 2002, Mathematical biosciences.

[7]  J. Felsenstein.  CONFIDENCE LIMITS ON PHYLOGENIES: AN APPROACH USING THE BOOTSTRAP , 1985, Evolution; international journal of organic evolution.

[8]  Josepa Ribes,et al.  Primary liver cancer: worldwide incidence and trends. , 2004, Gastroenterology.

[9]  Michiie Sakamoto,et al.  Pathologic diagnosis of early hepatocellular carcinoma: A report of the international consensus group for hepatocellular neoplasia , 2009, Hepatology.

[10]  Minshan Chen,et al.  Analysis of loss of heterozygosity on chromosome 4q in hepatocellular carcinoma using high-throughput SNP array. , 2009, Oncology reports.

[11]  W. Blanc.  Tumors of the Liver and Intrahepatic Bile Ducts , 1958, Pediatrics.

[12]  P. Hofschneider,et al.  The preS2/S region of integrated hepatitis B virus DNA encodes a transcriptional transactivator , 1990, Nature.

[13]  N. Wong,et al.  A comprehensive karyotypic study on human hepatocellular carcinoma by spectral karyotyping , 2000, Hepatology.

[14]  A. Schäffer,et al.  Chromosome abnormalities in ovarian adenocarcinoma: III. Using breakpoint data to infer and test mathematical models for oncogenesis , 2000, Genes, chromosomes & cancer.

[15]  M. Emi,et al.  Localization of a Target Region of Allelic Loss to a 1‐cM Interval on Chromosome 16p.13.13 in Hepatocellular Carcinoma , 1999, Japanese journal of cancer research : Gann.

[16]  Roland Penzel,et al.  Oncogenetic tree models based on cytogenetic data: new insights into the development of epithelial tumors of the thymus. , 2005, Cancer genetics and cytogenetics.

[17]  Y. Shiratori,et al.  Hepatitis C virus nonstructural region 5A protein is a potent transcriptional activator. , 1997, Journal of virology.

[18]  L. Qin,et al.  The abnormalities of chromosome 8 in two hepatocellular carcinoma cell clones with the same genetic background and different metastatic potential , 2003, Journal of Cancer Research and Clinical Oncology.

[19]  R Core Team,et al.  R: A language and environment for statistical computing. , 2014 .

[20]  Derek Y. Chiang,et al.  Focal gains of VEGFA and molecular classification of hepatocellular carcinoma. , 2008, Cancer research.

[21]  H. Edmondson,et al.  Primary carcinoma of the liver. A study of 100 cases among 48,900 necropsies , 1954, Cancer.

[22]  T. Okanoue,et al.  Large scaled analysis of hepatitis B virus (HBV) DNA integration in HBV related hepatocellular carcinomas , 2005, Gut.

[23]  I. Wanless,et al.  Terminology of nodular hepatocellular lesions , 1995 .

[24]  P. Schirmacher,et al.  Molecular pathogenesis of human hepatocellular carcinoma. , 2002, Advances in cancer research.

[25]  Yoshiharu Matsuura,et al.  The core protein of hepatitis C virus induces hepatocellular carcinoma in transgenic mice , 1998, Nature Medicine.

[26]  S. Badvie.  Hepatocellular carcinoma , 2000, Postgraduate medical journal.

[27]  Seth Sullivant,et al.  Markov models for accumulating mutations , 2007, 0709.2646.

[28]  Wen-Hui Su,et al.  OncoDB.HCC: an integrated oncogenomic database of hepatocellular carcinoma revealed aberrant cancer target genes and loci , 2006, Nucleic Acids Res..

[29]  Nicholas Eriksson,et al.  Conjunctive Bayesian networks , 2006, math/0608417.

[30]  K. Koike.  Hepatitis B virus HBx gene and hepatocarcinogenesis. , 1995, Intervirology.

[31]  Sang-hun Park.  Expanding the Natural History of Nonalcoholic Steatohepatitis: from Cryptogenic Cirrhosis to Hepatocellular Carcinoma , 2003 .

[32]  Yoshio Yamaoka,et al.  SIAH1 inactivation correlates with tumor progression in hepatocellular carcinomas , 2003, Genes, chromosomes & cancer.

[33]  R. Eils,et al.  Etiology‐dependent molecular mechanisms in human hepatocarcinogenesis , 2007, Hepatology.

[34]  Tae-Min Kim,et al.  Clinical implication of recurrent copy number alterations in hepatocellular carcinoma and putative oncogenes in recurrent gains on 1q , 2008, International journal of cancer.

[35]  P. Schirmacher,et al.  Frequent genomic imbalances suggest commonly altered tumour genes in human hepatocarcinogenesis , 2001, British Journal of Cancer.

[36]  B. Gunawan,et al.  Maximum likelihood estimation of oncogenetic tree models. , 2004, Biostatistics.

[37]  P. Schirmacher,et al.  Chromosome alterations in human hepatocellular carcinomas correlate with aetiology and histological grade – results of an explorative CGH meta-analysis , 2005, British Journal of Cancer.

[38]  S. Hirohashi,et al.  Allele loss on chromosome 16 associated with progression of human hepatocellular carcinoma. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[39]  M. Gebel,et al.  Induction of aneuploidy by increasing chromosomal instability during dedifferentiation of hepatocellular carcinoma. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[40]  Feng Jiang,et al.  Distance-Based Reconstruction of Tree Models for Oncogenesis , 2000, J. Comput. Biol..

[41]  J. Ludes-Meyers,et al.  Frequent downregulation and loss of WWOX gene expression in human hepatocellular carcinoma , 2004, British Journal of Cancer.

[42]  S. Hirohashi,et al.  Aberrations of the tumor suppressor p53 and retinoblastoma genes in human hepatocellular carcinomas. , 1991, Cancer research.

[43]  C. Bréchot,et al.  The detection of hepatitis B virus (HBV) in HBsAg negative individuals with primary liver cancer , 1991, Digestive Diseases and Sciences.

[44]  Fuchu He,et al.  Genome-wide association study identifies 1p36.22 as a new susceptibility locus for hepatocellular carcinoma in chronic hepatitis B virus carriers , 2010, Nature Genetics.